Skip to content

Brain Development Research Program

Disorders of Cerebral Development: A Phenotypic and Genetic Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00305305
Enrollment
2000
Registered
2006-03-21
Start date
2003-08-01
Completion date
2027-01-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aicardi Syndrome, Brain Disorders

Keywords

Agenesis Corpus Callosum, Polymicrogyria, Dandy-Walker, Brain Malformation, Autism, Epilepsy, Mental Retardation, MRI, Agenesis of the Corpus Callosum (complete or partial), Confirmed by a brain MRI., Aicardi Syndrome.

Brief summary

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.

Detailed description

We are studying both the genetics and clinical features of these disorders. We hope to understand the problems faced by individuals with these disorders as well as their causes. In the future, we hope to develop therapies that are geared specifically for individuals based on the underlying biology. To participate in the study, you will be asked to provide a copy of the magnetic resonance imaging (MRI) documenting Agenesis Corpus Callosum (ACC), Polymicrogyria (PMG), or Dandy-Walker malformation (DWM), clinical information, and saliva or blood samples from the affected individual and from the parents. Please see contact information and our webpage below.

Interventions

None listed

Sponsors

University of California, San Francisco
Lead SponsorOTHER
University of Washington
CollaboratorOTHER
California Institute of Technology
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation * Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain

Exclusion criteria

* Fully formed but hypoplastic corpus callosum

Countries

United States

Contacts

CONTACTCarolyn Le, BA, BS
Carolyn.Le@ucsf.edu415-502-8039
PRINCIPAL_INVESTIGATORElliott H Sherr, MD, PhD

University of California, San Francisco

PRINCIPAL_INVESTIGATORJames Barkovich, MD

University of California, San Francisco

PRINCIPAL_INVESTIGATORPratik Mukherjee, MD, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026